Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy
Conditions: Locally Advanced Squamous Non-small Cell Lung Cancer Interventions: Drug: Recombinant Human Endostatin Injection Sponsors: The First Affiliated Hospital of Xinxiang Medical College Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Lung Cancer | Non-Small Cell Lung Cancer | Research